Shields K - Search Results

1

Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy.

Haas DM, Gallauresi B, Shields K, Zeitlin D, Clark SM, Hebert MF, Ren Z, Nallani SC, Meslin EM, Feibus KB, Koren G, Goebel WS, Easterling T, Denne SC, Flockhart DA, Renbarger JL. Haas DM, et al. Among authors: shields k. Clin Transl Sci. 2011 Jun;4(3):204-9. doi: 10.1111/j.1752-8062.2011.00280.x. Clin Transl Sci. 2011. PMID: 21707952 Free PMC article.

2

Monitoring outcomes of pregnancy following drug exposure: a company-based pregnancy registry program.

Shields KE, Wiholm BE, Hostelley LS, Striano LF, Arena SR, Sharrar RG. Shields KE, et al. Drug Saf. 2004;27(6):353-67. doi: 10.2165/00002018-200427060-00001. Drug Saf. 2004. PMID: 15144230

3

Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry.

Wilson E, Goss MA, Marin M, Shields KE, Seward JF, Rasmussen SA, Sharrar RG. Wilson E, et al. J Infect Dis. 2008 Mar 1;197 Suppl 2:S178-84. doi: 10.1086/522136. J Infect Dis. 2008. PMID: 18419394

4

Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry.

Shields KE, Galil K, Seward J, Sharrar RG, Cordero JF, Slater E. Shields KE, et al. Obstet Gynecol. 2001 Jul;98(1):14-9. doi: 10.1016/s0029-7844(01)01384-9. Obstet Gynecol. 2001. PMID: 11430950

5

An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.

Lehman HP, Chen J, Gould AL, Kassekert R, Beninger PR, Carney R, Goldberg M, Goss MA, Kidos K, Sharrar RG, Shields K, Sweet A, Wiholm BE, Honig PK. Lehman HP, et al. Among authors: shields k. Clin Pharmacol Ther. 2007 Aug;82(2):173-80. doi: 10.1038/sj.clpt.6100233. Epub 2007 May 16. Clin Pharmacol Ther. 2007. PMID: 17507922

6

Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004.

Fiore M, Shields KE, Santanello N, Goldberg MR. Fiore M, et al. Among authors: shields ke. Cephalalgia. 2005 Sep;25(9):685-8. doi: 10.1111/j.1468-2982.2004.00929.x. Cephalalgia. 2005. PMID: 16109049

7

Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine.

Dana A, Buchanan KM, Goss MA, Seminack MM, Shields KE, Korn S, Cunningham ML, Haupt RM. Dana A, et al. Obstet Gynecol. 2009 Dec;114(6):1170-1178. doi: 10.1097/AOG.0b013e3181c2a122. Obstet Gynecol. 2009. PMID: 19935016

8

Pregnancy outcomes after maternal exposure to simvastatin and lovastatin.

Pollack PS, Shields KE, Burnett DM, Osborne MJ, Cunningham ML, Stepanavage ME. Pollack PS, et al. Birth Defects Res A Clin Mol Teratol. 2005 Nov;73(11):888-96. doi: 10.1002/bdra.20181. Birth Defects Res A Clin Mol Teratol. 2005. PMID: 16163683

9

Pharmacoepidemiologic implications of erroneous varicella vaccinations in pregnancy through confusion with Varicella zoster immune globulin.

Wise RP, Braun MM, Seward JF, Mootrey GT, Shields KE, Salive ME, Krause PR. Wise RP, et al. Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):651-4. doi: 10.1002/pds.749. Pharmacoepidemiol Drug Saf. 2002. PMID: 12512240

10

Exclusion of pregnant women from industry-sponsored clinical trials.

Shields KE, Lyerly AD. Shields KE, et al. Obstet Gynecol. 2013 Nov;122(5):1077-1081. doi: 10.1097/AOG.0b013e3182a9ca67. Obstet Gynecol. 2013. PMID: 24104789 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters